Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea

JaeHee Cheon, Nayoung Kim, Dong Ho Lee, Jung Mogg Kim, Joo Sung Kim, Hyun Chae Jung, In Sung Song

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

OBJECTIVES: To determine the long-term outcomes in terms of Helicobacter pylori and ulcer recurrence after second-line eradication with bismuth-containing quadruple regimens in Korea. METHODS: Sixty-seven patients with peptic ulcer disease after successful eradication using second-line quadruple therapies were prospectively followed up 1 month after treatment and then every 6 months or when dyspeptic symptoms reappeared to ascertain H. pylori and ulcer status. RESULTS: Three patients were lost during follow-up. The median duration of follow-up of the remaining 64 patients was 26.8 months. H. pylori recurrence occurred in 11 of these 64 patients (17.2%), giving a calculated reinfection rate of 6.0% per patient-year. Only one of the 11 patients was reinfected by 12 months after treatment completion. Four of 11 patients (36.4%) who became reinfected experienced peptic ulcer recurrence, but none of 53 patients who were not reinfected experienced recurrence. No evidence was obtained to indicate that the reinfection rate depended on the age, sex, ulcer location, or eradication regimens. The relapse of dyspeptic symptoms was the only factor predictive of H. pylori recurrence. CONCLUSION: This study suggests that the recurrence rate of H. pylori at 1 year after second-line, bismuth-containing quadruple therapy is low, but the annual reinfection rate is as high as 6%. Surveillance for H. pylori reinfection facilitating peptic ulcer recurrence may be warranted even after a second eradication, especially when dyspeptic symptoms reappear in Korea.

Original languageEnglish
Pages (from-to)515-519
Number of pages5
JournalEuropean Journal of Gastroenterology and Hepatology
Volume18
Issue number5
DOIs
Publication statusPublished - 2006 May 1

Fingerprint

Bismuth
Korea
Helicobacter pylori
Recurrence
Peptic Ulcer
Ulcer
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Cheon, JaeHee ; Kim, Nayoung ; Lee, Dong Ho ; Kim, Jung Mogg ; Kim, Joo Sung ; Jung, Hyun Chae ; Song, In Sung. / Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea. In: European Journal of Gastroenterology and Hepatology. 2006 ; Vol. 18, No. 5. pp. 515-519.
@article{77d883da534b4a7c8dacce7620cc8d96,
title = "Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea",
abstract = "OBJECTIVES: To determine the long-term outcomes in terms of Helicobacter pylori and ulcer recurrence after second-line eradication with bismuth-containing quadruple regimens in Korea. METHODS: Sixty-seven patients with peptic ulcer disease after successful eradication using second-line quadruple therapies were prospectively followed up 1 month after treatment and then every 6 months or when dyspeptic symptoms reappeared to ascertain H. pylori and ulcer status. RESULTS: Three patients were lost during follow-up. The median duration of follow-up of the remaining 64 patients was 26.8 months. H. pylori recurrence occurred in 11 of these 64 patients (17.2{\%}), giving a calculated reinfection rate of 6.0{\%} per patient-year. Only one of the 11 patients was reinfected by 12 months after treatment completion. Four of 11 patients (36.4{\%}) who became reinfected experienced peptic ulcer recurrence, but none of 53 patients who were not reinfected experienced recurrence. No evidence was obtained to indicate that the reinfection rate depended on the age, sex, ulcer location, or eradication regimens. The relapse of dyspeptic symptoms was the only factor predictive of H. pylori recurrence. CONCLUSION: This study suggests that the recurrence rate of H. pylori at 1 year after second-line, bismuth-containing quadruple therapy is low, but the annual reinfection rate is as high as 6{\%}. Surveillance for H. pylori reinfection facilitating peptic ulcer recurrence may be warranted even after a second eradication, especially when dyspeptic symptoms reappear in Korea.",
author = "JaeHee Cheon and Nayoung Kim and Lee, {Dong Ho} and Kim, {Jung Mogg} and Kim, {Joo Sung} and Jung, {Hyun Chae} and Song, {In Sung}",
year = "2006",
month = "5",
day = "1",
doi = "10.1097/00042737-200605000-00010",
language = "English",
volume = "18",
pages = "515--519",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea. / Cheon, JaeHee; Kim, Nayoung; Lee, Dong Ho; Kim, Jung Mogg; Kim, Joo Sung; Jung, Hyun Chae; Song, In Sung.

In: European Journal of Gastroenterology and Hepatology, Vol. 18, No. 5, 01.05.2006, p. 515-519.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea

AU - Cheon, JaeHee

AU - Kim, Nayoung

AU - Lee, Dong Ho

AU - Kim, Jung Mogg

AU - Kim, Joo Sung

AU - Jung, Hyun Chae

AU - Song, In Sung

PY - 2006/5/1

Y1 - 2006/5/1

N2 - OBJECTIVES: To determine the long-term outcomes in terms of Helicobacter pylori and ulcer recurrence after second-line eradication with bismuth-containing quadruple regimens in Korea. METHODS: Sixty-seven patients with peptic ulcer disease after successful eradication using second-line quadruple therapies were prospectively followed up 1 month after treatment and then every 6 months or when dyspeptic symptoms reappeared to ascertain H. pylori and ulcer status. RESULTS: Three patients were lost during follow-up. The median duration of follow-up of the remaining 64 patients was 26.8 months. H. pylori recurrence occurred in 11 of these 64 patients (17.2%), giving a calculated reinfection rate of 6.0% per patient-year. Only one of the 11 patients was reinfected by 12 months after treatment completion. Four of 11 patients (36.4%) who became reinfected experienced peptic ulcer recurrence, but none of 53 patients who were not reinfected experienced recurrence. No evidence was obtained to indicate that the reinfection rate depended on the age, sex, ulcer location, or eradication regimens. The relapse of dyspeptic symptoms was the only factor predictive of H. pylori recurrence. CONCLUSION: This study suggests that the recurrence rate of H. pylori at 1 year after second-line, bismuth-containing quadruple therapy is low, but the annual reinfection rate is as high as 6%. Surveillance for H. pylori reinfection facilitating peptic ulcer recurrence may be warranted even after a second eradication, especially when dyspeptic symptoms reappear in Korea.

AB - OBJECTIVES: To determine the long-term outcomes in terms of Helicobacter pylori and ulcer recurrence after second-line eradication with bismuth-containing quadruple regimens in Korea. METHODS: Sixty-seven patients with peptic ulcer disease after successful eradication using second-line quadruple therapies were prospectively followed up 1 month after treatment and then every 6 months or when dyspeptic symptoms reappeared to ascertain H. pylori and ulcer status. RESULTS: Three patients were lost during follow-up. The median duration of follow-up of the remaining 64 patients was 26.8 months. H. pylori recurrence occurred in 11 of these 64 patients (17.2%), giving a calculated reinfection rate of 6.0% per patient-year. Only one of the 11 patients was reinfected by 12 months after treatment completion. Four of 11 patients (36.4%) who became reinfected experienced peptic ulcer recurrence, but none of 53 patients who were not reinfected experienced recurrence. No evidence was obtained to indicate that the reinfection rate depended on the age, sex, ulcer location, or eradication regimens. The relapse of dyspeptic symptoms was the only factor predictive of H. pylori recurrence. CONCLUSION: This study suggests that the recurrence rate of H. pylori at 1 year after second-line, bismuth-containing quadruple therapy is low, but the annual reinfection rate is as high as 6%. Surveillance for H. pylori reinfection facilitating peptic ulcer recurrence may be warranted even after a second eradication, especially when dyspeptic symptoms reappear in Korea.

UR - http://www.scopus.com/inward/record.url?scp=33744786268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744786268&partnerID=8YFLogxK

U2 - 10.1097/00042737-200605000-00010

DO - 10.1097/00042737-200605000-00010

M3 - Article

VL - 18

SP - 515

EP - 519

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 5

ER -